Market Pulse

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Tracking Sensex

Tracking Sensex

Top five losers, gainers this week.  Full Article 

AirAsia  in India

AirAsia in India

AirAsia India launch seen in Q4; may order 50 more Airbus jets: CEO.  Full Article 

Jet-Etihad Deal

Jet-Etihad Deal

Jet Airways shareholders approve Etihad deal.  Full Article 

Tata Steel Shines

Tata Steel Shines

Tata Steel surges; Q4 operating profit beats f'cast.  Full Article 

RBI's May Review

RBI's May Review

Subbarao overrules panel view on rate action in May.  Full Article 

Abe's Agenda

Abe's Agenda

Special Report - The deeper agenda behind "Abenomics".  Full Article 

Bernanke Impact

Bernanke Impact

U.S. Fed enters delicate new phase of communication  Full Article | Related Story 

Revenge of Markets

Revenge of Markets

For months, markets have been dancing to central bankers' tune, but that may now be changing, writes James Saft.  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Venezuela's Chavez undergoing 'tough' chemotherapy - VP

Related Topics

Track BSE Sectoral Indices

Track Markets: BSE Sectoral Indices

Track and analyse performance of all BSE sectoral indices and other global indices on a single page.   Full Coverage 

A man walks in front of a poster of Venezuelan President Hugo Chavez outside a military hospital where he is being treated in Caracas February 25, 2013. REUTERS/Carlos Garcia Rawlins

A man walks in front of a poster of Venezuelan President Hugo Chavez outside a military hospital where he is being treated in Caracas February 25, 2013.

Credit: Reuters/Carlos Garcia Rawlins

CARACAS | Sat Mar 2, 2013 7:11pm IST

CARACAS (Reuters) - Venezuela's ailing President Hugo Chavez has been undergoing "tougher" new treatment for cancer including chemotherapy at the military hospital where he has been for the last two weeks, his vice-president said.

Speaking late on Friday after a Catholic Mass to pray for Chavez's health, Maduro described how the socialist president had personally given the order to leave Cuba in mid-February, two months after his latest cancer surgery there.

"He said 'I've taken the decision to return to Venezuela, I'm going to enter a new phase of complementary treatments, tougher and more intense, I want to be in Caracas,'" Maduro said.

"Do you know what the complementary treatments are? They are the chemotherapies applied to patients after operations," he added outside a chapel in the Caracas military hospital.

Apart from one set of photos showing Chavez in a Havana hospital bed, he has not been seen nor heard from in public since December 11 surgery in Cuba, his fourth operation since the disease was detected in mid-2011.

Furious at rumors swirling all week that Chavez may have died, Maduro said chemotherapy was only possible because his condition had improved in January after a delicate few weeks following the December operation.

Chavez's No. 2 urged Venezuelans to be on the guard against "rumor-mongers" and "destabilizers," saying right-wing politicians in the United States were in league with Venezuela's opposition to spread lies about his boss.

"Sadly, the opposition live in a world of hatred, wrongdoing, bad feelings and bad desires," Maduro said, adding that Chavez had become sick from over-working.

"He neglected his own body to give our people his work, his love, his life," Maduro said, confirming Chavez was still using a tracheal tube to breathe and was communicating with family and aides through written messages and other "creative" means.

Opposition leaders have accused Maduro of lying about Chavez's condition, and several dozen anti-government students have chained themselves up in public to demand proof that the president is alive and in Venezuela. (Reporting by Andrew Cawthorne; Editing by Vicki Allen)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.